Kainos Laboratories, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kainos Laboratories with three other
pharmaceutical manufacturers in Asia:
Albert David Limited
sales of 2.87 billion Indian Rupees [US$39.73 million]
(2.71 billion Indian Rupees [US$37.39 million]
Mangalam Drugs & Organics Limited
based in India
(2.79 billion Indian Rupees [US$38.61 million]
During the year ended March of 2018, sales at
Kainos Laboratories were ¥4.39 billion (US$39.09 million).
decrease of 6.7%
versus 2017, when the company's sales were ¥4.70 billion.